Why is Aurobindo Pharma falling/rising?

As of 21-Jul, Aurobindo Pharma Ltd. is experiencing a decline in its stock price, currently at 1,139.55, reflecting a decrease of -1.45 (-0.13%). The stock has been losing value for the last two days, with a total return of -1.21% during this period. In terms of performance against benchmarks, the stock has shown a modest increase of +0.16% over the past week and +4.00% over the past month, while it has significantly underperformed over the year with a return of -14.55%. The company has a low Debt to Equity ratio and an attractive valuation with a Price to Book Value of 2, but its operating profit growth has been sluggish at an annual rate of 5.00% over the last five years, contributing to the negative sentiment around the stock.
Broader market context indicates that while the Sensex has generated a return of +5.20% year-to-date, Aurobindo Pharma has lagged significantly with a -14.65% return in the same timeframe. The stock's recent performance is also affected by falling investor participation, as evidenced by a 50.2% drop in delivery volume compared to the five-day average. Despite high institutional holdings at 41.31%, which typically suggest confidence in the stock's fundamentals, the overall market conditions and the company's flat results have led to a perception of poor long-term growth potential, further influencing the stock's downward movement.